Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLX-787 for muscle cramps in Charcot-Marie-Tooth disease
NCT03254199Phase 2Terminated
- Sponsor
- Salarius Pharmaceuticals
- Start
- Oct 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of FLX-787 in Charcot-Marie-Tooth disease (CMT), sponsored by Salarius Pharmaceuticals. Started Oct 2017; status: terminated.
02
Drugs
FLX-787
03
Conditions
Charcot-Marie-Tooth disease (CMT)
Beyond the preview
Go deeper on NCT03254199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03254199.